ClinicalTrials.Veeva

Menu
L

Leben Salud | Fundacion Medica de Rio Negro y Neuquen

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Platinum
Etoposide
Bemarituzumab
Durvalumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression (FORTITUDE-301)

The primary objectives of this study are to observe the safety and tolerability of bemarituzumab and to evaluate preliminary antitumor activity.

Enrolling
Solid Tumors
Drug: Bemarituzumab

The primary objective of this study is to compare the efficacy of tarlatamab plus durvalumab with durvalumab alone on prolonging overall survival (OS...

Enrolling
Small-Cell Lung Cancer
Extensive-Stage Small-Cell Lung Cancer
Drug: Tarlatamab
Drug: Durvalumab

Trial sponsors

Amgen logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems